HS-10390

N/A

Report date: 2026/05/21 20:00:22
NME

Base Information

Drug NameHS-10390
Drug Alias NameHS-10390HS10390
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonistsAngiotensin II Receptor Type 1 antagonists
TargetsEndothelin receptor type AAngiotensin II Receptor Type 1
Therapy Area/IndicationsRenal Insufficiency, ChronicGlomerulosclerosis, Focal SegmentalGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChangzhou Hengbang Pharmaceutical Co LtdShanghai Hansoh Biomedical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hansoh Pharmaceutical Group Co LtdShanghai Hansoh Biomedical Co LtdChangzhou Hengbang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicGlomerulosclerosis, Focal SegmentalGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A